The review, led by Hening Pujasari of Universitas Indonesia together with colleagues in Indonesia and Malawi, followed the PRISMA 2020 reporting guidelines and was prospectively registered with PROSPERO. The team searched ten electronic databases from their inception through October 2025, looking for both randomized and non-randomized studies that assessed sleep outcomes in people living with HIV using validated instruments. Those instruments included the Pittsburgh Sleep Quality Index, the Insomnia Severity Index, actigraphy, and polysomnography—the gold-standard laboratory measurement of sleep architecture. Two reviewers independently screened the records and extracted the data, a standard safeguard against individual judgment errors.

Methodological rigor was a defining feature of the analysis. Risk of bias was assessed with design-appropriate tools: the Cochrane RoB 2.0 instrument for randomized trials and Joanna Briggs Institute tools for other study designs. Importantly, the authors judged bias domain by domain rather than collapsing everything into a single score, which preserves the nuance that a trial might be well-conducted overall yet vulnerable in one specific area such as blinding or outcome measurement. Eleven studies ultimately met the eligibility criteria, spanning a diverse array of interventions and comparison conditions.

That diversity posed a genuine analytical challenge. Because the eleven studies differed substantially in how their comparator groups were structured and which outcome instruments they used, the researchers restricted quantitative pooling a priori to studies with comparable controlled post-intervention Pittsburgh Sleep Quality Index data. Only three randomized trials—by Molavi and colleagues in 2020, Qi and colleagues in 2024, and Wen and colleagues in 2025, together enrolling 187 participants—met that comparability threshold. These were combined using a random-effects model, the standard approach when true effect sizes are assumed to vary across studies rather than being identical.

The pooled result was striking. The standardized mean difference, expressed as Hedges g, came out at −1.38 with a 95 percent confidence interval of −1.78 to −0.99, and heterogeneity was modest at I² = 27.5 percent. In plain terms, the interventions improved subjective sleep quality by an amount conventionally considered large, and the variation between studies was relatively low. Because only three trials were pooled, the team also ran a Hartung-Knapp sensitivity analysis, which is better suited to small numbers of studies than the default methods. That check produced a wider but still statistically significant interval of −2.31 to −0.48, reinforcing confidence in the direction of the effect even under conservative assumptions.

The authors went further with robustness testing. A leave-one-out analysis, in which the pooled estimate is recalculated after omitting each study in turn, retained both the direction and the statistical significance of the effect no matter which single trial was excluded. This is a meaningful safeguard in small meta-analyses, where a single influential study can sometimes drive the entire result. With only three pooled studies, however, publication bias could not be reliably assessed—a limitation the researchers acknowledge explicitly, since small meta-analyses are precisely the setting in which unpublished negative trials are hardest to detect.

Not all the evidence could be pooled. One study used a mixed pharmacological comparator, and several others reported outcomes with instruments other than the Pittsburgh Sleep Quality Index, so these were synthesized narratively rather than merged into the quantitative estimate. This decision reflects a growing consensus in evidence synthesis: forcing heterogeneous studies into a single pooled number can produce a deceptively precise figure that obscures real clinical differences. By pre-specifying their pooling criteria, the authors traded breadth of quantification for integrity of the estimate they did report.

Why does sleep matter so much in HIV care? The review’s background notes that sleep disturbances among people living with HIV are associated with poorer quality of life, suboptimal adherence to antiretroviral therapy, and adverse clinical outcomes. Adherence is particularly critical: consistent daily medication is what keeps viral load suppressed and prevents drug resistance. A patient who sleeps badly may struggle with the energy, mood, and routine organization that adherence demands, creating a pathway from disturbed sleep to worse virological control. Interventions that improve sleep without adding drug interactions or side effects therefore carry substantial public health potential, especially since they are described as scalable and low-risk.

The interventions represented in the eligible studies spanned several categories, including cognitive behavioural therapy for insomnia, brief behavioural treatment for insomnia, mindfulness-based cognitive therapy, emotional freedom techniques, and sleep hygiene training. The authors are careful not to crown a winner: with only three studies in the pooled analysis and considerable heterogeneity in intervention type, no single category can be established as superior. This is an honest reading of the data. Clinicians hoping for a definitive prescription—say, eight sessions of CBT-I over sleep hygiene pamphlets—will not find one here, and the authors explicitly say the findings should be regarded as preliminary pending larger, standardized trials.

What the review does establish is a foundation. It demonstrates that the question is answerable with rigorous methods, that subjective sleep quality as measured by the Pittsburgh Sleep Quality Index responds to non-pharmacological intervention in this population, and that future trials should standardize their outcome instruments and comparator structures so that their results can be combined. For the roughly thirty-eight million people living with HIV worldwide, many of whom report poor sleep, the message is cautiously encouraging: drug-free approaches appear to work, the effect may be large, and the research community now has a clear template for confirming it at scale.

Subject of Research: Non-pharmacological interventions for improving sleep quality in people living with HIV

Article Title: Non-pharmacological interventions to improve sleep quality among people living with HIV: a systematic review and meta-analysis

Article References: Pujasari, H., Putri, Y. S. E., Umar, E., Nurhayati, N., Friska, F., & Mulyana, A. S. (2026). Non-pharmacological interventions to improve sleep quality among people living with HIV: a systematic review and meta-analysis. BMC Public Health. https://doi.org/10.1186/s12889-026-29661-7

Image Credits: AI Generated

DOI: 10.1186/s12889-026-29661-7

Keywords: HIV, sleep quality, non-pharmacological interventions, systematic review, meta-analysis, PSQI, CBT-I, mindfulness, sleep hygiene, public health, antiretroviral therapy, insomnia

The study, led by Zihang Tong and colleagues at the First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, pooled evidence from 96 randomized controlled trials encompassing 18,419 adult participants. The research team searched PubMed, the Cochrane Library, Embase, and Web of Science through October 2025, then used network meta-analysis — a statistical framework that combines both direct comparisons between treatments and indirect comparisons linked through a common control — to rank six digital interventions: digital cognitive behavioral therapy (dCBT), digital mindfulness-based therapy (dMBT), digital brief behavioral therapy (dBBT), circadian rhythm support (CRS), virtual reality (VR), and tele-neurofeedback (NFB). By folding every trial into a single evidence network anchored on a shared control node, the method allows treatments never tested against each other in the same trial to be compared with remarkable statistical efficiency.

The headline finding concerns the Insomnia Severity Index, or ISI, a seven-item questionnaire that scores insomnia symptoms from 0 to 28. Compared with control treatment, dCBT reduced ISI scores by an average of 4.24 points, with a 95 percent confidence interval of −4.83 to −3.65 — an estimate supported by moderate-certainty evidence under the CINeMA framework. That figure is not just statistically significant; it crosses the minimal clinically important difference, the threshold — set at 4 points for the ISI in this analysis — beyond which patients and clinicians should actually notice a change. In other words, dCBT is the only intervention in the network whose effect on the core outcome of insomnia severity was unambiguously meaningful for real patients.

The detailed picture across other outcomes is more nuanced. dCBT also significantly improved PSQI scores (a reduction of 2.28 points), shortened subjective sleep onset latency by about 12.6 minutes, raised subjective sleep efficiency by 7.27 percentage points, and cut subjective wake after sleep onset by roughly 17.2 minutes. Yet none of these secondary effects reached their respective minimal clinically important differences, which the authors defined as, for example, at least a 3-point PSQI change or a 20-minute reduction in latency. Digital mindfulness-based therapy produced a smaller but significant ISI reduction of 2.28 points and shortened objectively measured sleep onset latency by 7.96 minutes, the latter based on moderate-certainty evidence from polysomnography and actigraphy studies. Virtual reality, evaluated through an inconsistency model because of statistical heterogeneity, reduced objectively measured wake after sleep onset by 13.38 minutes — significant, but again below the clinical threshold.

Direct head-to-head comparisons within the network reinforced dCBT’s dominance. It outperformed dMBT on the ISI (by 1.96 points) and on subjective total sleep time (by about 10 minutes), beat VR on the PSQI, and surpassed circadian rhythm support on sleep latency and sleep efficiency measures. Using SUCRA statistics, which express the probability that a treatment ranks best, dCBT topped the charts for the ISI (93.3 percent), the PSQI (95.8 percent), subjective sleep onset latency (95.0 percent), and subjective sleep efficiency (93.0 percent). Three interventions — tele-neurofeedback, digital brief behavioral therapy, and circadian rhythm support — showed no statistically significant benefits over control for any outcome, effectively dropping out of the clinical conversation until better evidence emerges.

The authors went well beyond the headline averages. Subgroup analyses probed whether effects differed by control group type, therapist guidance, treatment duration, and population. Notably, dCBT performed as well as face-to-face CBT where such comparisons existed, held up against active controls rather than only passive waitlists, and worked whether delivered with a therapist in the loop or fully automated — the ISI effect was −4.48 points with guidance versus −4.10 points without, a gap of less than half a point. Treatment duration mattered little for the core outcome: the ISI effect was identical (−4.24 points) whether programs ran eight weeks or longer. Effects were somewhat larger in people with insomnia symptoms who lack a formal diagnosis than in diagnosed patients, suggesting those with less entrenched sleep pathology may respond more readily to structured digital programs.

Sensitivity analyses added important caveats about who benefits. dCBT’s effects proved stable across pregnant women, cancer patients, and people with depression or anxiety, indicating broad applicability. dMBT’s efficacy, by contrast, appeared inflated in pregnant women under certain control designs and weaker in cancer survivors, and its improvement on the PSQI was fragile among depressed patients. VR was the most volatile intervention of all: its estimated effects swung dramatically depending on which small studies were included, leading the authors to urge caution about deploying VR in oncology, acute medical settings, and populations with severe somatic disease.

The study is candid about its limitations, and readers should absorb them. Only two of the 96 trials were judged low risk of bias overall, with 94 showing some concerns — especially around outcome measurement, where participants inevitably know what treatment they are receiving, inflating expectancy effects on subjective questionnaires. Heterogeneity was high for the ISI and PSQI, objective sleep outcomes rested on few trials with small samples, roughly 40 trials had potential industry funding, and the analysis captured only immediate post-treatment results with no follow-up data on whether benefits persist. The treatment taxonomy also followed a Chinese expert consensus rather than international regulatory frameworks, which may limit direct comparability with other classification schemes.

Still, the practical implications are hard to escape. For clinicians building insomnia care pathways, the evidence reasonably supports dCBT as the primary digital option, given its clinically meaningful reduction in insomnia severity. dMBT emerges as a reasonable alternative or adjunct — particularly for patients who prefer mindfulness approaches or struggle to adhere to CBT — even though its benefits did not reach clinical significance thresholds. The absence of patient and public involvement in the analysis, the authors acknowledge, means real-world preferences around acceptability remain underexplored. What the study delivers is something prior reviews could not: a single network in which six different digital therapies, from smartphone-delivered CBT to immersive VR, compete on equal statistical footing to answer the question patients actually ask — which one is best.

The research team, funded by Tianjin science and health programs and registered prospectively on PROSPERO, concludes that future work should prioritize large-scale, high-quality randomized trials with standardized interventions, objective outcome frameworks, and long-term follow-up. Until then, this analysis stands as the most complete map of the digital sleep-therapy landscape — one that confirms the promise of treatment delivered by app, but also warns that statistical significance alone is not the same as a patient sleeping meaningfully better. For the 16.2 percent of adults worldwide reporting clinically significant insomnia, the difference between those two thresholds is exactly the kind of precision that evidence-based medicine is meant to provide.

Subject of Research: Comparative effectiveness of digital therapeutics for improving sleep quality in adults with insomnia

Article Title: The effectiveness of digital therapeutics in improving sleep quality: a systematic review and network meta-analysis

Article References: Tong, Z., Ye, G., Fan, S., Li, Y., Zhang, J., Zhang, H., Chen, Q., Wang, H., Li, H., & Wang, J. (2026). The effectiveness of digital therapeutics in improving sleep quality: a systematic review and network meta-analysis. BMC Medicine, 24(1), Article 526. https://doi.org/10.1186/s12916-026-05129-8

Image Credits: AI Generated

DOI: 10.1186/s12916-026-05129-8

Keywords: digital therapeutics, insomnia, sleep quality, network meta-analysis, digital cognitive behavioral therapy, mindfulness, virtual reality, tele-neurofeedback, circadian rhythm support, randomized controlled trials, PSQI, Insomnia Severity Index

The research, published in BMC Geriatrics, drew its participants from the Neyshabur Longitudinal Study on Ageing, an ongoing population-based project designed to track health and wellbeing in a large cohort of older Iranians. From this framework, the investigators analyzed a representative sample of 647 adults aged 60 and older who had been diagnosed with type 2 diabetes. The average participant was 67.5 years old, and women made up just over half of the group at 55.8 percent. By focusing specifically on older adults with diabetes, the team targeted a population in which sleep disturbances are known to be especially common and particularly damaging to quality of life.

Methodologically, the study relied on two well-established and validated instruments, each with a long track record in geriatric research. Physical activity was measured using the Persian version of the Physical Activity Scale for the Elderly, known as PASE, which captures not only leisure-time exercise but also the everyday movements that dominate life in older age: household chores, caregiving, walking, and occupational activity. Sleep quality was assessed with the Persian version of the Pittsburgh Sleep Quality Index, or PSQI, a questionnaire that evaluates multiple dimensions of sleep, including duration, latency, disturbances, efficiency, and daytime dysfunction. Higher PSQI scores indicate poorer sleep, which is a crucial detail for interpreting the study’s statistical results.

The numbers themselves tell an interesting story about this population. The mean PASE score was 74.4, with a striking standard deviation of 70.8, revealing enormous variability in how active these older adults were; some participants were nearly sedentary while others maintained substantial daily movement. The mean PSQI score was 6.9 with a standard deviation of 4.1, a value that sits near the commonly used threshold of 5 above which sleep quality is generally considered poor. In other words, the average participant in this cohort was already teetering on the edge of clinically meaningful sleep problems, underscoring why identifying modifiable factors like physical activity matters so much for this group.

To isolate the independent contribution of physical activity, the researchers employed a multiple linear regression framework, progressively adjusting for potential confounders across several models. The fully adjusted analysis, designated Model 4, incorporated age, sex, education, marital status, income, and current job status. Because regression estimates in smaller or skewed samples can be sensitive to individual data points, the team also applied bootstrap regression with 1,000 replications, a resampling technique that provides more robust confidence intervals by repeatedly re-estimating the association across thousands of simulated versions of the dataset. This statistical rigor strengthens confidence that the reported effect is not an artifact of a few unusual participants.

The headline finding emerged clearly from this fully adjusted model: physical activity and sleep quality were significantly and inversely associated, with a beta coefficient of -0.0057 and a 95 percent confidence interval spanning -0.0100 to -0.0014, and a p-value of 0.009. Because lower PSQI scores mean better sleep, the negative coefficient translates directly into a positive message: higher physical activity was associated with better sleep quality. The authors themselves are careful to characterize the magnitude of this association as modest, and the confidence interval, while excluding zero, indicates an effect that is statistically reliable but small at the level of the individual score. In practical terms, the association suggests that meaningful shifts in daily activity could nudge sleep quality in the right direction, even if no single change will transform a poor sleeper into a perfect one.

Equally instructive are the secondary findings about who slept worst in this cohort. Female sex was significantly associated with poorer sleep quality, carrying a beta of 1.85 with a 95 percent confidence interval of 1.20 to 2.49 and a p-value below 0.001. Financial hardship also left a measurable mark: participants in the lowest income category, labeled income status 3 in the analysis, showed a beta of 2.13 with a confidence interval of 1.13 to 3.13 and a p-value below 0.001. These results align with a broader literature showing that sleep problems in later life are not distributed evenly, but cluster among women and among those facing economic strain, possibly through channels such as stress, caregiving burdens, less comfortable sleeping environments, or untreated health complaints.

What might explain a biological link between movement and sleep in people with type 2 diabetes? Several mechanisms are plausible, though the study design cannot confirm any of them. Physical activity is known to improve insulin sensitivity and glycemic control, and hyperglycemia itself is associated with nocturnal awakenings, polyuria, and restless legs-like symptoms, so better metabolic regulation could plausibly translate into fewer sleep disruptions. Activity also increases exposure to daylight, raises body temperature in ways that reinforce circadian amplitude, promotes the buildup of sleep-promoting adenosine in the brain, and reduces symptoms of depression and anxiety that frequently sabotage sleep in chronic illness. Each of these pathways offers a testable hypothesis for future longitudinal work.

The authors are appropriately cautious about the limits of their design. Because the study is cross-sectional, capturing a single snapshot in time, it cannot establish causality. People who sleep poorly may simply move less because they are exhausted, rather than inactivity causing poor sleep; reverse causation remains a live possibility. Residual confounding is also possible, since no adjustment set can capture every relevant variable such as medication use, diabetes duration, comorbidities, or body mass index. The modest effect size further counsels against overstating the clinical implications. Still, the use of a representative sample, validated instruments, and bootstrap-robust regression gives the finding a solid evidentiary footing within its scope.

For clinicians and public health planners, the study offers a low-cost, low-risk lever worth pulling. Encouraging older adults with type 2 diabetes to accumulate more daily activity, whether through structured exercise, walking programs, or simply more household and occupational movement, is already recommended for metabolic and cardiovascular benefits, and this research suggests sleep health may be an additional dividend. The finding that women and those with financial difficulties carry a heavier sleep burden also points toward the need for targeted screening in these subgroups. As the population ages and diabetes prevalence climbs worldwide, understanding how everyday behavior shapes one of the most fundamental pillars of health, sleep, becomes not an academic curiosity but a practical necessity, and this Iranian cohort study provides a carefully measured step in that direction.

Subject of Research: The association between physical activity and sleep quality in older adults with type 2 diabetes

Article Title: Higher physical activity is independently associated with better sleep quality in older Iranian adults with type 2 diabetes

Article References: Darrudi, A., Ameli, E., Moghadam, S. G., & Abbasi, A. (2026). Higher physical activity is independently associated with better sleep quality in older Iranian adults with type 2 diabetes. BMC Geriatrics. https://doi.org/10.1186/s12877-026-08364-z

Image Credits: AI Generated

DOI: 10.1186/s12877-026-08364-z

Keywords: physical activity, sleep quality, type 2 diabetes, older adults, PSQI, PASE, cross-sectional study, Iran, geriatrics, regression analysis, sleep disorders, aging

The study, conducted by Pınar Göbel of Gülhane School of Health Sciences at the University of Health Sciences in Ankara and Hilal Doğan Güney of the Nutrition and Diet Unit at the Safranbolu District Health Directorate in Karabuk, enrolled volunteer women who applied to a healthy living center in Turkey. The researchers chose a single-arm, pre-post design, meaning that all participants received the intervention and were compared against their own baseline measurements rather than against a control group. This approach is common in early-stage research because it allows scientists to assess feasibility, refine protocols and generate preliminary effect estimates before committing to the expense and complexity of a full randomized controlled trial.

The intervention itself was deliberately practical. For twelve weeks, participants received nutrition counseling and psychological support, and they were encouraged to walk regularly, accumulating at least 150 minutes of physical activity per week. That threshold corresponds to the minimum level of moderate activity recommended by major public health bodies worldwide, making the program something that could, in principle, be replicated in community settings without specialized equipment or supervision. There were no experimental drugs, no restrictive crash diets and no laboratory-based exercise regimens, just a coordinated package of dietary guidance, emotional support and a walking target that many older adults could realistically pursue.

To measure the program’s effects, the researchers deployed a battery of well-validated instruments. Sleep quality was assessed with the Pittsburgh Sleep Quality Inventory, or PSQI, a questionnaire widely regarded as the standard tool for capturing subjective sleep disturbances, including difficulties falling asleep, nighttime awakenings and daytime dysfunction. Psychological well-being was tracked with the Psychological Well-Being Scale in the Elderly, abbreviated as PWBSE, which probes dimensions of emotional and existential health in later life. Physical activity levels were quantified using the short form of the International Physical Activity Questionnaire, known as IPAQ, a tool designed for population surveillance of movement and sedentary behavior.

Beyond the questionnaires, the team collected objective data. Anthropometric measurements, which typically include body weight, body mass index and related indices of body composition, were recorded at baseline and again at the end of the intervention. Blood samples were drawn to assess biochemical parameters, providing a window into metabolic health that self-report alone cannot supply. This combination of subjective and objective endpoints matters because lifestyle interventions often produce changes that participants feel before they can be measured, and conversely, because measurable metabolic shifts can occur even when a person’s subjective sense of change is muted.

The results were striking in their consistency. At week twelve, compared with baseline, participants showed significant improvements in their PWBSE scores, their IPAQ scores and their PSQI scores, with all three comparisons reaching the p < 0.001 threshold, a level of statistical significance that indicates the observed changes would be extremely unlikely to arise from chance alone. In practical terms, the women reported sleeping better, moving more and feeling psychologically stronger after three months of the combined program. The fact that sleep quality improved alongside activity and well-being is particularly noteworthy, given that poor sleep is both common in older adults and closely intertwined with obesity, mood disorders and cardiovascular risk.

The biochemical and anthropometric data told a similar story. Blood parameters showed significant positive changes over the course of the intervention, and the researchers highlighted one finding in particular: high-density lipoprotein, or HDL, the cholesterol fraction often described as protective for cardiovascular health, increased significantly by week twelve. Rising HDL in the context of a lifestyle program is a meaningful signal, because higher levels of this lipoprotein are associated with more efficient reverse cholesterol transport, the process by which cholesterol is carried away from artery walls back to the liver. Meanwhile, the anthropometric measurements also shifted in a favorable direction, suggesting that the women’s body composition improved over the twelve weeks.

Why might a combined intervention outperform what any single component might achieve on its own? The researchers’ multimodal framework reflects an increasingly influential view in geriatric health: that sleep, diet, physical activity and psychological state form an interlocking system. Regular moderate exercise is known to deepen slow-wave sleep and stabilize circadian rhythms, while better sleep in turn regulates appetite hormones such as leptin and ghrelin, making dietary change easier to sustain. Psychological support may reinforce both threads by reducing stress-related eating and improving adherence to the walking target. The significant gains in well-being observed in this study are consistent with that feedback-loop model, in which progress in one domain cascades into the others.

The study’s limitations are as important as its findings. Because there was no control group, some of the improvement could reflect regression to the mean, placebo effects, the simple passage of time or the attention participants received from the research team, a phenomenon sometimes called the Hawthorne effect. The sample of thirty-six women recruited from a single healthy living center in Turkey is small and may not represent older women elsewhere. The authors themselves are explicit on this point: their preliminary findings suggest that a twelve-week multimodal intervention may be associated with improvements in sleep quality, body composition and biochemical parameters in older women, but future randomized controlled trials are needed to confirm these initial observations. The study was retrospectively registered at ClinicalTrials.gov under the identifier NCT07740902, received ethics approval from the Karabuk University Non-Interventional Clinical Research Ethics Committee and was conducted with informed consent from all participants in accordance with the Helsinki declaration.

Even with those caveats, the research carries real weight for anyone thinking about healthy aging. Sleep disturbances, weight gain and metabolic decline are among the most common complaints of later life, and pharmacological options for addressing them are limited or carry side effects. A program built from nutrition counseling, psychological support and 150 minutes of weekly walking is inexpensive, scalable and low-risk. If larger controlled trials replicate what this pilot observed, the implications could extend well beyond research clinics, pointing toward community-based lifestyle programs as a frontline tool for helping older women sleep more soundly, move more freely and age with healthier bodies and minds.

Subject of Research: Effects of a 12-week multimodal lifestyle intervention on sleep quality and body composition in older women

Article Title: Changes in sleep quality and body composition following a multimodal lifestyle intervention in older women: a single-arm pilot study

Article References: Göbel, P., & Güney, H. D. (2026). Changes in sleep quality and body composition following a multimodal lifestyle intervention in older women: a single-arm pilot study. BMC Geriatrics. https://doi.org/10.1186/s12877-026-08322-9

Image Credits: AI Generated

DOI: 10.1186/s12877-026-08322-9

Keywords: sleep quality, body composition, older women, lifestyle intervention, obesity, physical activity, nutrition counseling, psychological well-being, HDL cholesterol, pilot study, healthy aging, PSQI

The scientific stakes are higher than they might first appear. Adolescents and young adults, often abbreviated as AYAs in oncology, occupy an awkward middle ground in cancer care. They are too old for most pediatric protocols and too young for the geriatric pathways that dominate adult oncology, and their survival rates have historically improved more slowly than those of either children or older adults. Previous research has shown that AYA cancer patients tend to engage in riskier health behaviors than older patients, including smoking, physical inactivity, and poor sleep habits. But when researchers tried to pin down whether AYA patients sleep worse specifically because of cancer, the literature turned contradictory. Some studies reported dramatically elevated rates of insomnia in young survivors; others found sleep quality roughly comparable to that of the general population. The inconsistency left clinicians without a clear mandate to screen for sleep problems in this group.

To resolve the question, a team led by Carolin Wieland of the Department of Medical Psychology and Medical Sociology at the Comprehensive Cancer Center Central Germany, University Medical Center Leipzig, recruited 407 AYA cancer patients aged 18 to 39 at diagnosis and compared them with 372 healthy participants aged 18 to 45. Data were collected between May and September 2019. The patients had a mean age of 34.8 years and were predominantly female, at 75.2 percent, while the healthy comparison group averaged 32.3 years of age and was 61.8 percent female. The design is notable for what it avoided: rather than comparing patients against published population norms, which can drift over time and across cultures, the researchers built a matched healthy comparison group and measured both groups with the same instruments during the same window.

The central measuring stick was the Pittsburgh Sleep Quality Index, or PSQI, a validated questionnaire that has become the de facto international standard for assessing subjective sleep over the preceding month. The PSQI does not merely ask whether someone sleeps badly; it decomposes sleep into seven component scores, covering subjective sleep quality, sleep latency, sleep duration, habitual sleep efficiency, sleep disturbances, use of sleep medication, and daytime dysfunction. This decomposition matters clinically, because two patients with identical total scores can have entirely different problems, one lying awake for hours and another sleeping a full eight hours yet waking exhausted. By analyzing the components separately, the Leipzig team could see precisely where the cancer patients’ sleep broke down.

The answer was: almost everywhere, but modestly and consistently. AYA cancer patients reported significantly poorer subjective sleep quality, with an effect size of d equal to 0.31, along with lower sleep efficiency at d equal to 0.15, more frequent sleep disturbances at d equal to 0.23, greater use of sleep medication at d equal to 0.25, and higher daytime dysfunction at d equal to 0.29. In the language of behavioral statistics, these are small to moderate effect sizes, which is precisely why the field has struggled. No single number screams for attention, yet the pattern is coherent and spans five of the seven PSQI components. Patients did not merely feel that their sleep was worse; they were also less efficient sleepers, more often medicated, and more functionally impaired during the day. Daytime dysfunction, the component most tightly linked to quality of life, fatigue, and cognitive performance at work or in education, showed one of the largest gaps between the groups.

Perhaps more revealing than the group comparison is what the regression analyses uncovered about who sleeps worst within the patient group. Using multiple regression, the researchers tested a battery of sociodemographic, clinical, and psychosocial variables measured with validated instruments: general self-efficacy, social support, anxiety and depression assessed with the Hospital Anxiety and Depression Scale, quality of life measured with the EORTC questionnaires, unmet supportive care needs captured by the Supportive Care Needs Survey, lack of energy, and physical activity. The model explained a substantial share of the variance in sleep quality, with an adjusted R-squared of 0.35, and three psychological variables stood out. Anxiety, depression, and unmet needs related to lack of energy were all significantly associated with worse PSQI scores, alongside reduced quality of life.

This triangulation of sleep with mood and energy is not a statistical accident, sleep scientists argue, but a reflection of shared biology and shared psychology. Anxiety prolongs sleep latency by keeping the arousal system switched on at bedtime; depression fragments sleep architecture and produces early-morning waking; and the profound fatigue that many cancer patients describe, sometimes called lack of energy in supportive care research, is bidirectionally entangled with sleep, each worsening the other in a feedback loop. The fact that these associations held after adjustment suggests that sleep problems in young cancer patients are not an isolated symptom but part of a broader psychosocial burden. For clinicians, that means a patient who reports insomnia may be signaling anxiety or depression that has not yet been voiced, and conversely, a patient being treated for distress should be asked how they are sleeping.

The authors are careful about what the study can and cannot show. As an observational comparison, it cannot disentangle whether cancer and its treatments cause the sleep deficits, whether pre-existing vulnerabilities in some patients contribute to both poorer sleep and poorer coping with the disease, or whether the psychological consequences of a cancer diagnosis at a formative age drive the effect. The female predominance in the patient sample, at 75.2 percent, also limits generalizability, since sex differences in sleep are well documented. Still, the consistency of the deficits across five PSQI components, in a sample of more than 400 patients against a concurrent healthy group, gives the findings a weight that earlier single-arm studies lacked, and it aligns with the broader picture of AYA patients carrying a distinctive burden of health behavior risks and unmet supportive care needs.

The practical prescription that emerges from the AYA-LE data is disarmingly simple: ask. The authors conclude that sleep disturbances deserve greater attention in survivorship care and recommend routine assessment of sleep quality to identify AYA patients who could benefit from further evaluation and appropriate support. Routine screening with a tool as brief as the PSQI costs minutes, yet it could route young patients toward cognitive behavioral therapy for insomnia, evaluation of anxiety and depression, or targeted interventions for fatigue, rather than leaving them to self-medicate, as the elevated sleep medication use in this sample suggests many already do. As the population of adolescent and young adult cancer survivors continues to grow, the study argues that the question, how are you sleeping? may be one of the most clinically loaded questions an oncologist can ask.

Subject of Research: Sleep quality and disturbances in adolescents and young adults with cancer compared to healthy controls

Article Title: Sleep quality and disturbances in adolescents and young adults with cancer compared to a healthy comparison group: results of the AYA-LE study

Article References: Wieland, C., Friedrich, M., Sender, A., Leuteritz, K., Brock, H., Geue, K., Mehnert-Theuerkauf, A., & Richter, D. (2026). Sleep quality and disturbances in adolescents and young adults with cancer compared to a healthy comparison group: results of the AYA-LE study. Journal of Cancer Research and Clinical Oncology. https://doi.org/10.1007/s00432-026-06627-1

Image Credits: AI Generated

DOI: 10.1007/s00432-026-06627-1

Keywords: AYA cancer, sleep quality, PSQI, sleep disturbances, psycho-oncology, anxiety, depression, fatigue, survivorship care, quality of life, young adults, supportive care